Data Bridge Market Research analyses that the targeted protein degradation market which was USD 103.31 million in 2021, would rocket up to USD 224.70 million by 2029, and is expected to undergo a CAGR of 10.20% during the forecast period 2022 to 2029.
Targeted proteolysis (TPD) has occurred as a fresh and advanced chemical tool and beneficial modality. By choosing a proteolytic pathway, TPD encourages the whole consent of protein molecules inside or outside the cell. While inventive proteolysis-targeting chimera (PROTAC) technology and molecular adhesives are interrupting the ubiquitin-proteasome system, original modalities hire autophagy or endo-lysosomal pathways.
Data Bridge Market Research analyses that the targeted protein degradation market which was USD 103.31 million in 2021, would rocket up to USD 224.70 million by 2029, and is expected to undergo a CAGR of 10.20% during the forecast period 2022 to 2029
Download Sample PDF Copy of this Report to understand structure of the complete report (Including Full TOC, Table & Figures) https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-targeted-protein-degradation-market
Market Overview
Targeted protein degradation is an innovatory pharmacological perception that grants practical drug development chances and is expected to announce a new paradigm in modern therapeutic interventions. Due to various reasons, conventional drugs/therapies have been partial in terms of their competence to target certain proteins of pathological significance.
Some of the major players operating in the targeted protein degradation market are:
- Eli Lilly and Company (U.S)
- Gilead Sciences, Inc. (U.S)
- GSK plc (U.K)
- Merck KGaA (Germany)
- Mission Therapeutics (U.K)
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S)
- Aurigene Discovery Technologies (India)
- Avista Pharma Solutions (U.S)
- Barbara Ann Karmanos Cancer Center (U.S)
- 5AM Venture Management LLC (U.S)
- AbbVie Inc (U.S)
- Almac Group (U.K)
-
Amgen Inc. (U.S)Global Targeted Protein Degradation Market ScopeThe Global targeted protein degradation market is segmented on the basis of type, application, therapeutic areas and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.Type
- Degronimids
- Immunomodulatory Drugs (IMiDs)
- Proteolysis-targeting chimeric molecules (PROTACs)
- Sudden acquired retinal degeneration syndrome (SARDs)
- Selective Estrogen Receptor Degraders (SERDs)
- Specific bromodomain
- Extra-terminal domain (BET)
-
Deubiquitinases (DUB) InhibitorsTherapeutic AreaInflammatory Disorders
- Neurological Disorders
- Oncological Disorders
- Respiratory Disorders
-
OtherRoute of AdministrationOral
- Intravenous
-
OthersApplicationHospital
-
Research InstituteTherapeutic Area
- Inflammatory Disorders
- Neurological Disorders
- Oncological Disorders
- Respiratory Disorders
-
Other Therapeutic AreasBrowse More About This Research Report @ https://www.databridgemarketresearch.com/reports/global-targeted-protein-degradation-marketTable of Content:
Chapter 1: Market overview
Chapter 2: Targeted Protein Degradation Market
Chapter 3: Regional analysis of the Targeted Protein Degradation Market industry
Chapter 4: Regional analysis of the Targeted Protein Degradation Market on types and applications
Chapter 5: Revenue analysis based on types and applications
Chapter 6: Market share
Chapter 7: Competitive Landscape
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
Chapter 9: Gross Margin and Price Analysis
Get the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-targeted-protein-degradation-market
Browse Trending Reports:
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: – [email protected]
Comments
0 comment